Lin, X., Li, Q., Lao, X., Yang, H., & Li, S. (2015). Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC). BMC Cancer.
Styl ChicagoLin, Xiao-jun, Qi-jiong Li, Xiang-ming Lao, Han Yang, a Sheng-ping Li. "Transarterial Injection of Recombinant Human Type-5 Adenovirus H101 in Combination With Transarterial Chemoembolization (TACE) Improves Overall and Progressive-free Survival in Unresectable Hepatocellular Carcinoma (HCC)." BMC Cancer 2015.
Citace podle MLALin, Xiao-jun, et al. "Transarterial Injection of Recombinant Human Type-5 Adenovirus H101 in Combination With Transarterial Chemoembolization (TACE) Improves Overall and Progressive-free Survival in Unresectable Hepatocellular Carcinoma (HCC)." BMC Cancer 2015.